The use of bloodstream infection mortality to measure the impact of antimicrobial stewardship interventions: assessing the evidence
This review sets out to evaluate the current evidence on the impact of inappropriate therapy on bloodstream infections (BSI) and associated mortality. Based on the premise that better prescribing practices should result in better patient outcomes, BSI mortality may be a useful metric to evaluate ant...
Main Authors: | Sonali Coulter, Jason A. Roberts, Krispin Hajkowicz, Kate Halton |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-03-01
|
Series: | Infectious Disease Reports |
Subjects: | |
Online Access: | http://www.pagepress.org/journals/index.php/idr/article/view/6849 |
Similar Items
-
Mortality after Delay of Adequate Empiric Antimicrobial Treatment of Bloodstream Infection
by: Merel M. C. Lambregts, et al.
Published: (2020-05-01) -
Management of antimicrobial resistance in a hospital: current state and future prospects
by: Karpov O.E., et al.
Published: (2020-12-01) -
Characteristics of Pediatric Antimicrobial Stewardship Programs: Current Status of the Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS) Collaborative
by: Christopher McPherson, et al.
Published: (2018-01-01) -
Long-Term Carbapenems Antimicrobial Stewardship Program
by: José Francisco García-Rodríguez, et al.
Published: (2021-12-01) -
Antimicrobial Stewardship: The Need to Cover All Bases
by: N. Deborah Friedman
Published: (2013-08-01)